960390-20-9

Upstream product

• 1659-31-0 2,2'-dipyridyl carbonate 
• 960390-18-5 1-(3-bromo-4-fluorophenyl)-1-pyridin-4-ylmethanamine 
• 96989-50-3 di-2-pyridyl thionocarbonate 

Downstream Products

• 960390-22-1 4-(pyridine-4-yl)-4-(3-bromo-4-fluorophenyl)-1,3-thiazolidine-2,5-dithione 
• 960390-26-5 3,3-difluoro-2,3,4,8-tetrahydroimidazo[1,5-a]pyrimidin-6-amine-4-(3-bromo-4-fluorobenzyl)pyridine 
• 960390-24-3 3,3-difluoro-3,4,7,8-tetrahydroimidazo[1,5-a]pyrimidine-6(2H)-thione-4-(3-bromo-4-fluorobenzyl)pyridine 

Relevant academic research and scientific papers

AMINO-IMIDAZOLONES AND THEIR USE AS A MEDICAMENT FOR TREATING COGNITIVE IMPAIRMENT, ALZHEIMER DISEASE, NEURODEGENERATION AND DEMENTIA

This invention relates to novel compounds having the structural formula (I) and to their pharmaceutically acceptable salt, compositions and methods of use. These novel compounds provide a treatment or prophylaxis of cognitive impairment, Alzheimer Disease, neurodegeneration and dementia.

AMINO- IMIDAZOLONES AND THEIR USE AS A MEDICAMENT FOR TREATING COGNITIVE IMPAIRMENT. ALZHEIMER DISEASE, NEURODEGENERATION AND DEMENTIA.

This invention relates to novel compounds having the structural formula I below: [Chemical formula should be inserted here. Please see paper copy] and to their pharmaceutically acceptable salt, compositions and methods of use. These novel compounds provide a treatment or prophylaxis of cognitive impairment, Alzheimer Disease, neurodegeneration and dementia.

New Compounds 319

This invention relates to novel compounds having the structural formula I below: and to their pharmaceutically acceptable salt, compositions and methods of use. These novel compounds provide a treatment or prophylaxis of cognitive impairment, Alzheimer Disease, neurodegeneration and dementia.